Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1Phase 1/2 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 49Genitourinary 15Head & Neck 6Thoracic 4Tumor-Agnostic 2Dermatologic 2Other solid neoplasm 1Gynecologic 1Breast 1

Conditions

Lung Neoplasms 3Small Cell Lung Carcinoma 1Neoplasm Metastasis 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Electroporation × Thoracic × Clear all
NCT05555342 2025-05-14

A Novel Method for Treating Lung Met w/Combo of Electric Fields & Rad Therapy: A Single-Arm

University of California, Irvine

Phase EARLY_PHASE1 Completed
6 enrolled
Thoracic

Lung Neoplasms, Neoplasm Metastasis

NCT02430753 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed
30 enrolled
Thoracic

Lung Neoplasms

NCT03183232 2020-07-13

Safety and Efficiency of γδ T Cell Against Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 1/2 Completed
30 enrolled
Thoracic

Lung Neoplasms

NCT03239171 2019-01-25

Bioinformation Therapy for Lung Cancer

Fuda Cancer Hospital, Guangzhou

Phase 2/3 Completed
120 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡